Data as of Sep 19
| -0.06 / -2.79%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +67.46% increase from the last price of 2.09.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.